{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T05:14:20Z","timestamp":1774070060423,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.bmc.2022.116910","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T12:02:42Z","timestamp":1656331362000},"page":"116910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["SPION nanoparticles for delivery of dopaminergic isoquinoline and benzazepine derivatives"],"prefix":"10.1016","volume":"69","author":[{"given":"Cristina","family":"Lucena-Serrano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Lucena-Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Valpuesta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Villaverde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Manuel L\u00f3pez-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Sarabia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Laurenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Rubio-Retama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Contreras-C\u00e1ceres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2022.116910_b0005","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1021\/ml3003742","article-title":"Nanomaterials for (nano)medicine","volume":"4","author":"Marchesan","year":"2013","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2022.116910_b0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.addr.2012.09.006","article-title":"Nanoparticles in cancer therapy and diagnosis","volume":"64","author":"Brigger","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmc.2022.116910_b0015","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3762\/bjnano.9.98","article-title":"Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations","volume":"9","author":"Jeevanandam","year":"2018","journal-title":"Beilstein J Nanotechnol"},{"key":"10.1016\/j.bmc.2022.116910_b0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/jnt1010002","article-title":"Synthesis of graphene nanoribbons\u2013hydroxyapatite nanocomposite applicable in biomedicine and theranostics","volume":"1","author":"Nosrati","year":"2020","journal-title":"J. Nanotheranostics"},{"key":"10.1016\/j.bmc.2022.116910_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0085835","article-title":"Toxicity assessment of silica coated iron oxide nanoparticles and biocompatibility improvement by surface engineering","volume":"9","author":"Malvindi","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmc.2022.116910_b0030","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11671-008-9174-9","article-title":"Magnetic iron oxide nanoparticles: synthesis and surface functionalization strategies","volume":"3","author":"Wu","year":"2008","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.bmc.2022.116910_b0035","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1002\/pola.27338","article-title":"Nanosegregated polymeric domains on the surface of Fe3O4@SiO2 particles","volume":"52","author":"Serrano-Ruiz","year":"2014","journal-title":"J. Polym. Sci. Part A Polym. Chem."},{"key":"10.1016\/j.bmc.2022.116910_b0040","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/jbm.b.32792","article-title":"Hybrid microparticles for drug delivery and magnetic resonance imaging","volume":"101","author":"Serrano-Ruiz","year":"2013","journal-title":"J. Biomed. Mater. Res. - Part B Appl. Biomater."},{"key":"10.1016\/j.bmc.2022.116910_b0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jneumeth.2018.10.015","article-title":"Drug targeting strategies into the brain for treating neurological diseases","volume":"311","author":"Barnabas","year":"2019","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bmc.2022.116910_b0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bmc.2022.116910_b0055","doi-asserted-by":"crossref","DOI":"10.1038\/nnano.2007.245","article-title":"On the brain","volume":"2","author":"Chun","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bmc.2022.116910_b0060","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ncl.2018.07.005","article-title":"Prion diseases","volume":"36","author":"Tee","year":"2018","journal-title":"Neurol Clin"},{"key":"10.1016\/j.bmc.2022.116910_b0065","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2174\/157341309789378014","article-title":"Recent advances in nanoneurology for drug delivery to the brain","volume":"5","author":"Kanwar","year":"2012","journal-title":"Curr Nanosci"},{"key":"10.1016\/j.bmc.2022.116910_b0070","doi-asserted-by":"crossref","DOI":"10.1177\/1179069518779829","article-title":"Physiological and functional basis of dopamine receptors and their role in neurogenesis: possible implication for Parkinson\u2019s disease","volume":"12","author":"Mishra","year":"2018","journal-title":"J. Exp. Neurosci."},{"key":"10.1016\/j.bmc.2022.116910_b0075","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bioorg.2018.06.038","article-title":"Synthesis and dopaminergic activity of a series of new 1-aryl tetrahydroisoquinolines and 2-substituted 1-aryl-3-tetrahydrobenzazepines","volume":"80","author":"Lucena-Serrano","year":"2018","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2022.116910_b0080","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1021\/cr050263h","article-title":"Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders","volume":"107","author":"Zhang","year":"2007","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2022.116910_b0085","first-page":"84","article-title":"Dopamine D1 receptor ligands: where are we now and where are we going","volume":"86","author":"Zhang","year":"2008","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmc.2022.116910_b0090","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejmech.2013.07.036","article-title":"2,3,9- and 2,3,11-Trisubstituted tetrahydroprotoberberines as D2 dopaminergic ligands","volume":"68","author":"P\u00e1rraga","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2022.116910_b0095","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejmech.2014.11.009","article-title":"Synthesis of hexahydrocyclopenta isoquinolines as a new class of dopaminergic agents","volume":"90","author":"P\u00e1rraga","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2022.116910_b0100","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/minf.201400093","article-title":"3-chlorotyramine acting as ligand of the D2 dopamine receptor. Molecular modeling, synthesis and D2 receptor affinity","volume":"34","author":"Angelina","year":"2015","journal-title":"Mol Inform"},{"key":"10.1016\/j.bmc.2022.116910_b0105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.15171\/apb.2016.044","article-title":"Nanomedicine in central nervous system (CNS) disorders: a present and future prospective","volume":"6","author":"Soni","year":"2016","journal-title":"Adv Pharm Bull"},{"key":"10.1016\/j.bmc.2022.116910_b0110","doi-asserted-by":"crossref","first-page":"15205","DOI":"10.1073\/pnas.1003388107","article-title":"Magnetic resonance monitoring of focused ultrasound\/magnetic nanoparticle targeting delivery of therapeutic agents to the brain","volume":"107","author":"Liu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bmc.2022.116910_b0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nnano.2014.254","article-title":"Towards non-invasive diagnostic imaging of early-stage Alzheimer\u2019s disease","volume":"10","author":"Viola","year":"2015","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.bmc.2022.116910_b0120","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.drudis.2017.11.010","article-title":"Personalized nanomedicine for CNS diseases","volume":"23","author":"Kaushik","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bmc.2022.116910_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jnt1010001","article-title":"Nanotheranostic, next generation prerequisite for better health","volume":"1","author":"Kaushik","year":"2018","journal-title":"J. Nanotheranostics"},{"key":"10.1016\/j.bmc.2022.116910_b0130","doi-asserted-by":"crossref","first-page":"18837","DOI":"10.1073\/pnas.1111405108","article-title":"Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging","volume":"108","author":"Koffie","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bmc.2022.116910_b0135","first-page":"63","article-title":"Synthesis of 3,4-dioxocularine and aristocularine alkaloids in a convergent route from aryloxy-phenyl acetamides involving oxalyl chloride-Lewis acid","volume":"v","author":"Suau","year":"2002","journal-title":"Arkivoc"},{"key":"10.1016\/j.bmc.2022.116910_b0140","doi-asserted-by":"crossref","first-page":"5725","DOI":"10.1016\/j.tet.2004.05.014","article-title":"The palladium(0) Suzuki cross-coupling reaction as the key step in the synthesis of aporphinoids","volume":"60","author":"Suau","year":"2004","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmc.2022.116910_b0145","doi-asserted-by":"crossref","first-page":"100614","DOI":"10.1039\/C6RA20055A","article-title":"Synthesis of catalytically active gold clusters on the surface of Fe3O4@SiO2 nanoparticles","volume":"6","author":"Alonso-Cristobal","year":"2016","journal-title":"RSC Adv"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622003030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622003030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:20:20Z","timestamp":1760836820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089622003030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":29,"alternative-id":["S0968089622003030"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2022.116910","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SPION nanoparticles for delivery of dopaminergic isoquinoline and benzazepine derivatives","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2022.116910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116910"}}